CV Sciences, Inc.
CVSIUS売上高
$14M
百万USD
営業利益
$-0M
百万USD
純利益
$-1M
百万USD
ROE
-65.3%
最新FY
EPS
$-0.01
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $5M | $-3M | - |
| FY2021 | Q2 | $5M | $-4M | - |
| FY2021 | Q3 | $5M | $-0M | $0.00 |
| FY2021 | FY | $20M | $-16M | $-0.14 |
| FY2022 | Q1 | $4M | $-2M | $-0.02 |
| FY2022 | Q2 | $4M | $-3M | $-0.03 |
| FY2022 | Q3 | $4M | $-1M | $-0.01 |
| FY2022 | FY | $16M | $-8M | $-0.07 |
| FY2023 | Q1 | $4M | $6M | $0.04 |
| FY2023 | Q2 | $4M | $-1M | $-0.01 |
| FY2023 | Q3 | $4M | $-0M | $0.00 |
| FY2023 | FY | $16M | $3M | $0.02 |
| FY2024 | Q1 | $4M | $-1M | $0.00 |
| FY2024 | Q2 | $4M | $-1M | $0.00 |
| FY2024 | Q3 | $4M | $-0M | $0.00 |
| FY2024 | FY | $16M | $-2M | $-0.01 |
| FY2025 | Q1 | $4M | $-0M | $0.00 |
| FY2025 | Q2 | $4M | $-0M | $0.00 |
| FY2025 | Q3 | $3M | $-0M | $0.00 |
| FY2025 | FY | $14M | $-1M | $-0.01 |
| FY2026 | Q1 | $3M | $-1M | $0.00 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | - | $24M | $20M | $16M | $16M | $16M | $14M |
| 営業利益 | $-13M | $-5M | $10M | $-17M | $-23M | $-18M | $-7M | $3M | $-2M | $-0M |
| 純利益 | $-14M | $-5M | $10M | $-17M | $-22M | $-16M | $-8M | $3M | $-2M | $-1M |
| 総資産 | $19M | $23M | $37M | $53M | $31M | $18M | $13M | $9M | $8M | $7M |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $13M | $16M | $30M | $29M | $11M | $4M | $-1M | $3M | $2M | $1M |
| 営業CF | - | $4M | $13M | $-2M | $-7M | $-7M | $-2M | $2M | $-1M | $-0M |
| EPS | - | - | $0.09 | $-0.17 | - | $-0.14 | $-0.07 | $0.02 | $-0.01 | $-0.01 |
| BPS | $0.21 | $0.18 | $0.31 | $0.29 | $0.11 | $0.03 | $-0.01 | $0.02 | $0.01 | $0.01 |
| ROE | -107.1% | -29.9% | 33.2% | -57.0% | -198.8% | -439.0% | 1057.1% | 106.9% | -133.4% | -65.3% |